ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Montana Woman’s Journey Highlights Advances in Lung Cancer Treatment at Intermountain Health

Genetic testing revealed Teresa Liter was predisposed to lung cancer and helped Intermountain Health identify her best treatment options.

(PRUnderground) December 19th, 2025

Teresa Liter went to her primary care provider to discuss pain from what she thought were kidney stones. Instead, her care team discovered lung cancer.

After sharing her concerns with Stefanie Rickhoff, PA, at the Intermountain Health Lockwood Clinic, Liter was referred for a CT scan at Intermountain Health St. Vincent Regional Hospital.

“It was by a fluke that we found it,” Liter said. “I was passing kidney stones and Stefanie did my lab work and annual checkup. My platelets were a little high, so she decided to order a scan.”

During the initial scan, a concerning mass was spotted in the bottom of Liter’s lung. Before she left the hospital, Rickhoff ordered another CT scan to get a full image of her lungs. Rickhoff asked Liter to meet her back at the clinic so that she could share the results in person.

“She told me, ‘I’ll be here as long as you need me.’ She stayed late at the clinic to meet with me and my husband and went through the X-rays and everything. By the time I got there, she had called oncology, scheduled the brain MRI, the CT scan, and the lung biopsy. Everything was set up,” Liter said.

Liter was diagnosed with stage 3 lung cancer. Genetic testing revealed she was predisposed to lung cancer and helped to direct her treatment options. Her treatment included chemotherapy, radiation, and immunotherapy. She worked closely with her oncology care team to ensure she was doing everything she could do to fight the spread of her cancer.

Liter’s courage was especially evident during her radiation treatments. “They targeted the nodes and the grapefruit-size tumor in my lung,” she said. “I had to do breathing exercises every day so I could make sure I could do the radiation and hold my breath. I had to keep the tumor very still for the radiation to target it. It was tough, but I was determined.”

She has responded well to the treatments. Almost a year later, she is finishing her final treatments with the hope of her cancer being in remission. Liter credits her incredible progress to the advancements in lung cancer treatment.

“For me, immunotherapy was a game changer,” Liter said. “Lung cancer patients didn’t have the same options … 20 years ago or even 10 years ago.”

Liter has personal knowledge and experience, as she lost her father to lung cancer. “Back then, your chances of survival were very, very minimal. Now there’s hope,” she said.

Throughout her treatment, Liter has made a point to bring that same hope to others undergoing treatment at the Intermountain Health Cancer Centers of Montana. “I like to introduce myself and talk to other patients, especially those who are newly diagnosed and waiting for their appointments,” she said. “I just try to check in on them and let them know they’re not alone.”

She credits her care team, especially Rickhoff, for her outcome. “When I saw her recently, I gave her the biggest hug and I just told her she saved my life, because she did,” she said.

“The past decade has seen a shift toward precision medicine in lung cancer, with targeted and immune therapies now central to management, resulting in substantial survival gains and improved quality of life for many patients,” said Rickhoff.

Liter also encourages others to be proactive about their health. “Go see your primary care provider and establish that relationship. It’s because I had that relationship that we even caught it,” she said.

Lung cancer is often diagnosed at an advanced stage when it is much harder to treat, but advancements in screening and treatment are continuously improving survival rates. If you have a history of smoking, a family history of lung cancer, or have any concerns, Rickhoff encourages individuals with questions to speak with their primary care provider or to learn more about lung cancer screenings to visit https://intermountainhealthcare.org/services/cancer-care/lung-cancer/lung-cancer-screening/

During this holiday season, Liter is grateful for her family, her care team, and the chance to share her story. “Whether you have cancer or not, you need to be present each day and be thankful,” she said.

About Intermountain Health

Headquartered in Utah with locations in six states and additional operations across the western U.S., Intermountain Health is a nonprofit system of 33 hospitals, over 400 clinics, medical groups with some 4,600 employed physicians and advanced care providers, a health plans division called Select Health with more than one million members, and other health services. Helping people live the healthiest lives possible, Intermountain is committed to improving community health and is widely recognized as a leader in transforming healthcare by using evidence-based best practices to consistently deliver high-quality outcomes at sustainable costs. For up-to-date information and announcements, please see the Intermountain Health newsroom at https://news.intermountainhealth.org/. For more information, see intermountainhealth.org/ or call 801-442-2000.

The post Montana Woman’s Journey Highlights Advances in Lung Cancer Treatment at Intermountain Health first appeared on

Press Contact

Name: Mike Paquette
Phone: 406.238.6220
Email: Contact Us

Original Press Release.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  228.53
+1.77 (0.78%)
AAPL  270.87
-1.32 (-0.48%)
AMD  213.66
+12.60 (6.27%)
BAC  55.13
+0.87 (1.60%)
GOOG  305.87
+2.12 (0.70%)
META  667.85
+3.40 (0.51%)
MSFT  484.97
+0.99 (0.20%)
NVDA  179.91
+5.77 (3.31%)
ORCL  193.84
+13.81 (7.67%)
TSLA  482.19
-1.18 (-0.24%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.